Table V.
Comparing % change in plasma inflammatory mediators from baseline (24 and 48 hr following infusion of rHDL or placebo)
| Inflammatory mediator | % Change from baseline (mean ± SD) 24 hr following infusion |
% Change from baseline (mean ± SD) 48 hr following infusion |
||||
|---|---|---|---|---|---|---|
| rHDL group | Placebo group | P value | rHDL group | Placebo group | P value | |
| IL-6 | −10.56 ± 17.72 | −2.56 ± 24.61 | 0.26 | 15.41 ± 91.11 | 62.99 ± 139.20 | 0.08 |
| CRP | 5.78 ± 55.86 | 55.88 ± 265.05 | 0.89 | 765.92 ± 772.53 | 3924.36 ± 6988.29 | 0.06 |
| MCP-1 | −5.04 ± 155.04 | −9.26 ± 63.57 | 0.40 | 35.70 ± 211.35 | 55.16 ± 105.04 | 0.14 |
| sCD40 | −27.29 ± 30.25 | −1.80 ± 22.84 | 0.15 | −16.79 ± 81.17 | −2.13 ± 29.88 | 0.19 |